SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Janine T Bryan, Barry Buckland, Jennifer Hammond, Kathrin U Jansen, Prevention of cervical cancer: journey to develop the first human papillomavirus virus-like particle vaccine and the next generation vaccine, Current Opinion in Chemical Biology, 2016, 32, 34

    CrossRef

  2. 2
    Yessi Jusman, Siew Cheok Ng, Noor Azuan Abu Osman, Intelligent Screening Systems for Cervical Cancer, The Scientific World Journal, 2014, 2014, 1

    CrossRef

  3. 3
    A. Trevisan, N. F. Schlecht, A. V. Ramanakumar, L. L. Villa, E. L. Franco, Human papillomavirus type 16 viral load measurement as a predictor of infection clearance, Journal of General Virology, 2013, 94, Pt_8, 1850

    CrossRef

  4. 4
    Elen B Blochin, Kay J Park, Satish K Tickoo, Victor E Reuter, Hikmat Al-Ahmadie, Urothelial carcinoma with prominent squamous differentiation in the setting of neurogenic bladder: role of human papillomavirus infection, Modern Pathology, 2012, 25, 11, 1534

    CrossRef

  5. 5
    Anna R. Giuliano, Joel M. Palefsky, Stephen Goldstone, Edson D. Moreira, Mary E. Penny, Carlos Aranda, Eftyhia Vardas, Harald Moi, Heiko Jessen, Richard Hillman, Yen-Hwa Chang, Daron Ferris, Danielle Rouleau, Janine Bryan, J. Brooke Marshall, Scott Vuocolo, Eliav Barr, David Radley, Richard M. Haupt, Dalya Guris, Efficacy of Quadrivalent HPV Vaccine against HPV Infection and Disease in Males, New England Journal of Medicine, 2011, 364, 5, 401

    CrossRef

  6. 6
    Maresa Montag, Thomas J. F. Blankenstein, Naim Shabani, Ansgar Brüning, Ioannis Mylonas, Evaluation of two commercialised in situ hybridisation assays for detecting HPV-DNA in formalin-fixed, paraffin-embedded tissue, Archives of Gynecology and Obstetrics, 2011, 284, 4, 999

    CrossRef

  7. 7
    Theodoros Kelesidis, Leo Aish, Michael A. Steller, Irene S. Aish, Junquing Shen, Periklis Foukas, John Panayiotides, George Petrikkos, Petros Karakitsos, Sotirios Tsiodras, Human Papillomavirus (HPV) Detection Using In Situ Hybridization in Histologic Samples, American Journal of Clinical Pathology, 2011, 136, 1, 119

    CrossRef

  8. 8
    Xingwei Wang, Bin Zheng, Shibo Li, Roy Zhang, John J. Mulvihill, Wei R. Chen, Hong Liu, Automated detection and analysis of fluorescent in situ hybridization spots depicted in digital microscopic images of Pap-smear specimens, Journal of Biomedical Optics, 2009, 14, 2, 021002

    CrossRef

  9. 9
    Elisabeth Barthell, Linn Woelber, Karin Hellner, Birka Camerer, Friederike Gieseking, Maik Hauschild, Ioannis Mylonas, Klaus Friese, Heather L. Sings, Radha Railkar, Christine Gause, Eliav Barr, Baseline characteristics and prevalence of HPV 6, 11, 16, 18 in young German women participating in phase III clinical trials of a quadrivalent HPV (6/11/16/18) vaccine, Archives of Gynecology and Obstetrics, 2009, 279, 6, 803

    CrossRef

  10. 10
    Renata De Marchi Triglia, Konradin Metze, Luiz Carlos Zeferino, Liliana A. Lucci De Angelo Andrade, HPV in situ hybridization signal patterns as a marker for cervical intraepithelial neoplasia progression, Gynecologic Oncology, 2009, 112, 1, 114

    CrossRef

  11. 11
    Eliav Barr, Heather L. Sings, Prophylactic HPV vaccines: New interventions for cancer control, Vaccine, 2008, 26, 49, 6244

    CrossRef

  12. 12
    Serge J. Smeets, Albertus T. Hesselink, Ernst-Jan M. Speel, Annick Haesevoets, Peter J.F. Snijders, Michael Pawlita, Chris J.L.M. Meijer, Boudewijn J.M. Braakhuis, C. René Leemans, Ruud H. Brakenhoff, A novel algorithm for reliable detection of human papillomavirus in paraffin embedded head and neck cancer specimen, International Journal of Cancer, 2007, 121, 11
  13. 13
    Kevin A. Ault, Effect of prophylactic human papillomavirus L1 virus-like-particle vaccine on risk of cervical intraepithelial neoplasia grade 2, grade 3, and adenocarcinoma in situ: a combined analysis of four randomised clinical trials, The Lancet, 2007, 369, 9576, 1861

    CrossRef

  14. 14
    Elmar A Joura, Sepp Leodolter, Mauricio Hernandez-Avila, Cosette M Wheeler, Gonzalo Perez, Laura A Koutsky, Suzanne M Garland, Diane M Harper, Grace WK Tang, Daron G Ferris, Marc Steben, Ronald W Jones, Janine Bryan, Frank J Taddeo, Oliver M Bautista, Mark T Esser, Heather L Sings, Micki Nelson, John W Boslego, Carlos Sattler, Eliav Barr, Jorma Paavonen, Efficacy of a quadrivalent prophylactic human papillomavirus (types 6, 11, 16, and 18) L1 virus-like-particle vaccine against high-grade vulval and vaginal lesions: a combined analysis of three randomised clinical trials, The Lancet, 2007, 369, 9574, 1693

    CrossRef

  15. 15
    Ciaran B. J. Woodman, Stuart I. Collins, Lawrence S. Young, The natural history of cervical HPV infection: unresolved issues, Nature Reviews Cancer, 2007, 7, 1, 11

    CrossRef

  16. 16
    N. Esther Babady, Human Papillomaviruses,